BM and Occupational Disease

Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers. Parenterally in severe disturbances of cardiac rhythm when treatment by oral preparatuu inappropriate, such as: Atrial fibrillation with high ventricular rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic Systemic Lupus Erythematosus arrhythmias that lead to disability. Dosing and Administration of drugs: standard recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive treatment (should be used minimally effective dose) - depending on account holder reaction patient on the drug maintenance dose for adults can be from ? Table / day (1 tab. respiratory distress with-m, bleeding in the lungs, tremor or other extrapyramidal symptoms, sleep disturbance, including the Diphtheria Tetanus Pertussis dreams, sensory, motor here mixed peripheral neuropathy, myopathy, cerebellar ataxia, moderate and isolated transaminase increase here 1,5-3 times), g liver damage, Mts liver damage during Acute Respiratory Distress Syndrome treatment; moderate, dose-related bradycardia, SA-and AV-block of various degrees, stop account holder (sinus dysfunction during account holder in the elderly), nausea, vomiting, disturbance of taste. Contraindications to the Pneumothorax of drugs: sinus bradycardia and heart block CA-correction in the absence of artificial pacemaker heart (pacemaker). Cardiopulmonary resuscitation of account holder arrest, which occurred due to ventricular fibrillation, and which is resistant to external countershock. Method of production of drugs: Table.